ConductScience.org, home

Paper15831777

Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.

Yuan CS and 7 others. J Clin Pharmacol, 2005. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. Papers, record 15831777. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15831777

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
PubMed
Journal
J Clin Pharmacol
PubMed
Year
2005
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2022-03-17
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yuan CSChun-Su
2Doshan HHarold
3Charney MRMartha R
4O'connor MMichael
5Karrison TTheodore
6Maleckar SAS A
7Israel RJRobert J
8Moss JJonathan

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal TransitMajor topic
NaltrexoneMajor topic
Narcotic AntagonistsMajor topic
Adult
Area Under Curve
Female
Half-Life
Humans
Injections, Intravenous
Male
Quaternary Ammonium Compounds

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
M01 RR00055NCRR NIH HHSUnited StatesM01RR000055PubMed and NIHNIH RePORTER
R01 CA79042NCI NIH HHSUnited StatesR01CA079042PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
40125716Gastrointestinal Transit Time Assessed Using a CT-Based Radiopaque Marker Method in Patients With Acute Pancreatitis During Methylnaltrexone Treatment.Neurogastroenterol Motil2025https://conductscience.org/library/papers/40125716PubMed
38863861Clinical Outcomes of Intravenous Methylnaltrexone in Children: A Single-Arm Retrospective Cohort Study.J Pediatr Pharmacol Ther2024https://conductscience.org/library/papers/38863861PubMed
34924020
Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial.
Trials2021https://conductscience.org/library/papers/34924020PubMed
28034973Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Pain Med2017https://conductscience.org/library/papers/28034973PubMed
27412108Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION).BMJ Open2016https://conductscience.org/library/papers/27412108PubMed
27033126Diagnosis and management of chronic constipation in adults.Nat Rev Gastroenterol Hepatol2016https://conductscience.org/library/papers/27033126PubMed
24871705Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers.Psychopharmacology (Berl)2015https://conductscience.org/library/papers/24871705PubMed
23563658Sphingolipids in lung endothelial biology and regulation of vascular integrity.Handb Exp Pharmacol2013https://conductscience.org/library/papers/23563658PubMed
23054089Meta-analysis of oro-cecal transit time in fasting subjects.Pharm Res2013https://conductscience.org/library/papers/23054089PubMed
23052993[Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].Schmerz2012https://conductscience.org/library/papers/23052993PubMed
22677527Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.Bioorg Med Chem2012https://conductscience.org/library/papers/22677527PubMed
21861811Most recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivatives.Mini Rev Med Chem2011https://conductscience.org/library/papers/21861811PubMed
21836816Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide.Clin Med Insights Oncol2011https://conductscience.org/library/papers/21836816PubMed
21197301Recent advances in the use of opioids for cancer pain.J Pain Res2009https://conductscience.org/library/papers/21197301PubMed
20981183Prophylactic use of laxative for constipation in critically ill patients.Ann Thorac Med2010https://conductscience.org/library/papers/20981183PubMed
20694079Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Core Evid2010https://conductscience.org/library/papers/20694079PubMed
20298531Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors.J Angiogenes Res2010https://conductscience.org/library/papers/20298531PubMed
20234787Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.Ther Clin Risk Manag2010https://conductscience.org/library/papers/20234787PubMed
19690895[Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].Schmerz2009https://conductscience.org/library/papers/19690895PubMed
19665953Current and novel therapeutic options for irritable bowel syndrome management.Dig Liver Dis2009https://conductscience.org/library/papers/19665953PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15831777

GET https://conductscience.org/api/papers/v1/15831777/cited_by?page=2